Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
15-valent pneumococcal conjugate vaccine
- Development stage
- Approved
- Lead developer
- Zhifei Biological
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
15-valent pneumococcal conjugate vaccine is a **multivalent conjugate vaccine candidate** developed in the provided clinical-trial context by Beijing Zhifei Lvzhu Biopharmaceutical for prevention of disease caused by *Streptococcus pneumoniae* serotypes included in the vaccine. It is intended to induce serotype-specific immune responses against pneumococcal capsular antigens and is being clinically evaluated in infants and young children, including primary-series and booster schedules and coadministration with diphtheria, tetanus, and acellular pertussis vaccine. The Zhifei pipeline identifies the program as PCV15 for invasive pneumococcal disease caused by 15 serotypes. ([en.zhifeishengwu.com](https://en.zhifeishengwu.com/about/zfgk))
- Other names
- PCV15PCV-15PCV 15
02
Targets
CPS (Streptococcus pneumoniae capsular polysaccharide)
Beyond the preview
Go deeper on 15-valent pneumococcal conjugate vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 15-valent pneumococcal conjugate vaccine.